REDWOOD CITY, Calif. and
SANTA CLARA, Calif., April 8, 2013 /PRNewswire/ -- Ingenuity® Systems,
a leading provider of biomedical information and analysis
solutions, and Affymetrix®, Inc. (NASDAQ: AFFX) today announced
that they will co-promote Ingenuity® iReport™ with
Affymetrix expression microarray products effectively eliminating a
bottleneck for researchers working with human, mouse and rat
applications by coupling a fast and accurate statistical analysis
and biological interpretation workflow with the gold-standard
platform for gene expression studies.
Affymetrix expression microarrays are the standard methodology
used for many research and discovery applications and when combined
with Ingenuity iReport, an interactive web-based report that
leverages the Ingenuity Knowledge Base of biological and chemical
findings from the peer reviewed literature and databases, deliver
researchers a 'sample to insight' continuous workflow allowing for
rapid, confident interpretation of results without the need for
bioinformatics experience or support.
"We are excited to partner with Ingenuity Systems to provide our
array users with access to the intuitive biological and statistical
analysis platform offered by iReport," said Kevin Cannon, Ph.D., SVP - Expression Business
Unit at Affymetrix. "Bundling together our robust expression
microarrays with the iReport platform will provide Affymetrix'
customers with a simple and accurate tool to convert data into
biologically relevant results."
"By leveraging Ingenuity iReport with Affymetrix gene expression
arrays for our study on a mouse model of Familial Hypertrophic
Cardiomyopathy, we accelerated our data interpretation several-fold
compared to using other analysis tools. Their rapid and
effectively-blind analysis provided an unbiased validation of our
data. Additionally, iReport allowed us to identify and explore
genes of interest found with Affymetrix gene chips, yet not
identified by other analysis tools," said Adrian Grimes, Ph.D., from the Department of
Pediatrics at the University of
Wisconsin.
About Ingenuity® Systems
Ingenuity® Systems is a leading provider of biomedical
information and analysis solutions for the exploration,
interpretation and analysis of complex biological systems in life
science research and molecular diagnostics. Today, Ingenuity's
solutions are used by tens of thousands of researchers and
clinicians at hundreds of leading pharmaceutical, biotechnology,
academic, diagnostic and clinical institutions worldwide.
About Affymetrix
Affymetrix' technologies are used by the world's top
pharmaceutical, diagnostic, and biotechnology companies, as well as
leading academic, government, and non-profit research institutes.
More than 2,300 microarray systems have been shipped around the
world and more than 48,000 peer-reviewed papers have been published
citing our technologies. Affymetrix is headquartered in
Santa Clara, California, and has
manufacturing facilities in Cleveland,
Ohio, San Diego,
Vienna and Singapore. The Company has about 1,100
employees worldwide and maintains sales and distribution operations
across Europe, Asia, and Latin
America. For more information about Affymetrix, please visit
www.affymetrix.com.
PLEASE NOTE: Affymetrix® and the Affymetrix logo are the
property of Affymetrix, Inc. All other trademarks are the property
of their respective owners.
Products mentioned in this release are for research use only.
Not for diagnostic procedures.
SOURCE Ingenuity Systems